Quality of Life assessment in the Collaborative Ocular Melanoma Study: Design and Methods COMS-QOLS Report No. 1

References

• Scotto J, Fraumeni JR, Lee JAH. Melanomas of the eye and other noncutaneous sites: Epidemiologic aspects. J Natl Cancer Inst 1976;56:489–91.
   Google Scholar
• Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988;32:239–51.
   PubMed Web of Science ®Google Scholar
• Diener-West M, Hawkins BS, Markowitz JM, Schachat AP. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 1992;11o:245–50.
   Google Scholar
• Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumor cells? Br J Ophthalmol 1978;62:420–5.
   Google Scholar
• Augsburger JJ, Gamel JVV, Sardi VF, Greenberg RA, Shields JA, Brady LW. Enucleation vs. cobalt plaque radiotherapy for malignant melanomas of the choroid and ciliary body. Arch Ophthalmol 1986;104:655–61.
   Google Scholar
• Char DH, Castro JR, Kroll SM, Irvine AR, Quivey JM, Stone RD. Five-year follow-up of helium ion therapy for uveal melanoma. Arch Ophthalmol 1990;108:209–14.
   PubMedGoogle Scholar
• Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Howard S, Fante RG, Albert DM. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology 1990;97:769–77.
   Google Scholar
• Foulds WS, Damato BE, Burton RL. Local resection versus enucleation in the management of choroidal melanoma. Eye 1987;1:676–9.
   Google Scholar
• Meyer-Schwickerath G, Vogel M. Treatment of malignant melanomas of the choroid by photocoagulation. Trans Ophthalmol Soc UK 1977;97: 416–20.
   PubMedGoogle Scholar
• Collaborative Ocular Melanoma Study Group: Design and methods of a clinical trial for a rare condition: The Collaborative Ocular Melanoma Study. Controlled Clin Trials 1993;14:362–91.
   PubMedGoogle Scholar
• Ware JE. Conceptualizing and measuring generic health outcomes. Cancer 1991;67(Suppl):774–9.
   Google Scholar
• Collaborative Ocular Melanoma Study Group: Complications of enucleation surgery. COMS Report No. 2. In: Franklin RM, editor. Proceedings of the Symposium on Retina and Vitreous, New Orleans Academy of Ophthalmology. New York: Kugler Publications, 1993: 181–90.
   Google Scholar
• Moy CS. Factors predicting choice of treatment for choroidal melanoma. Invest Ophthalmol Vis Sci 1993;34:967.
   Web of Science ®Google Scholar
• Edwards MG, Schachat AP. Impact of enucleation for choroidal melanoma on the performance of vision-dependent activities. Arch Ophthalmol 1991;109:519–21.
   PubMedGoogle Scholar
• Augsburger JJ, Goel SD. Visual function following enucleation or episcleral plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 1994;112:786–9.
   PubMedGoogle Scholar
• Johnson RN. Choroidal and Ciliary Body Malignant Melanoma: Diagnosis and Management. San Francisco: Retina Research Fund, 1993:4–5.
   Google Scholar
• Servodidio CA, Abramson DH. Presenting signs and symptoms of choroidal melanoma: What do they mean? Ann Ophthalmol 1992;24:190–4.
   PubMedGoogle Scholar
• Packer S, Stoller S, Lesser ML, Mandel FS, Finger PT. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology 1992;99: 767–74.
   Google Scholar
• Seddon JH, Gragoudas ES, Polivogianis L, et al.: Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology 1986;93:666–74.
   Google Scholar
• Char DH, Quivey JM, Castro JR, et al.: Helium ion versus iodine 125 brachytherapy in the management of uveal melanoma. Ophthalmology 1993;100: 1547–54.
   Google Scholar
• Klein R: Measures of outcome in current clinical trials of eye care. In: Drummond MF, editor. Measuring the Quality of Life of People with Visual Impairment. Proceedings of a Workshop. U.S. Department of Health and Human Services. NIH Publication No. 90-3078, 1990: 23–5.
   Google Scholar
• Legge GE. How visual impairment affects quality of life. In: Drummond MF, editor. Measuring the Quality of Life of People with Visual Impairment. Proceedings of a Workshop. U.S. Department of Health and Human Services. NIH Publication No. 90-3078, 1990: 17–8.
   Google Scholar
• Ferguson BA, Buxton MJ, Drummond MF. Measuring and valuing health status relating to visual impairment: A review of literature, concepts and methods. In: Drummond MF, editor. Measuring the Quality of Life of People with Visual Impairment. Proceedings of a Workshop. U.S. Department of Health and Human Services. NIH Publication No. 90-3078, 1990:69–92.
   Google Scholar
• Collaborative Ocular Melanoma Study: COMS Manual of Procedures. Springfield, VA: National Technical Information Service, 1990. NTIS accession no. PB90–115536.
   Google Scholar
• Stewart AL, Hays RD, Ware JE. The MOS Short-form General Health Survey. Med Care 1988;26:724–35.
   PubMed Web of Science ®Google Scholar
• Ware JE, Snow MC, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
   Google Scholar
• Ware JE, Sherbourne CD: The MOS 36-item Short-Form Health Survey (SF-36): Conceptual framework and item selection. Med Care 1992;30:473–83.
   PubMed Web of Science ®Google Scholar
• Kurtin PS, Davies AR, Meyer KB, DeGiacomo JM, Kantz ME. Patient-based health status measures in outpatient dialysis: early experiences in developing an outcomes assessment program. Med Care 1992;30(Suppl):MS136–49.
   Google Scholar
• Nerenz DR, Repasky DP, Whitehouse FW, Kahkonen DM. Ongoing assessment of health status in patients with diabetes mellitus. Med Care 1992;30(Suppl):MS112–24.
   Google Scholar
• McHorney CA, Ware JE, Rogers W, Raczek AE, Lu JFR. The validity and relative precision of MOS Short- and Long-Form Health Status scales and Dartmouth COOP Charts. Med Care 1992;30(Suppl):MS253–65.
   Google Scholar
• Ganz PA, Day R, Ware JE, Redmond C, Fisher B. Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Nal Cancer Inst 1995;87:1372–82.
   Google Scholar
• Mangione CM, Phillips RS, Seddon JM, Lawrence MG, Cook EF, Dailey R, Goldman L. Development of the 'Activities of Daily Vision Scale': A measure of visual functional status. Med Care 1992;3o:111i–26.
   Google Scholar
• Mangione CM, Lee PP, Berry SH, Hays RD, Janz NK, Klein R, Owsley C. Development of a questionnaire for the assessment of visual function. Invest Ophthalmol Vis Sci 1995;36:1962A.
   Google Scholar
• Mangione CM, Lee PP, Berry SH, Spritzer K, Janz NK, Klein R, Owsley C, Hays RD. The NEI-VFQ 51-item test version and its relationship with visual acuity across 5 diseases. Invest Ophthalmol Vis Sci 1996;37:873.
   Web of Science ®Google Scholar
• Gutierrez PR, Wilson MR, Johnson C, Gordon M, Cioffie G, Ritch R, Sherwood M, Curnow B, Mangione CM. Influence of glaucomatous field defects on health-related quality of life. Arch Ophthalmol 1997;115:777–84.
   Google Scholar
• Mangione CM, Berry S, Spritzer K, et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire. Results from focus groups with visually impaired persons. Arch Ophthalmol 1998;116:227–33.
   Google Scholar
• Moy CS, Melia BM, Gutierrez PR, Mangione CM. Assessment of visual functioning with the NEI-VFQ in patients with choroidal melanoma: a pilot study. Invest Ophthalmol Vis Sci 1997;38:5841.
   Web of Science ®Google Scholar
• Zigmund AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiat Scand 1983;67:361–70.
   PubMed Web of Science ®Google Scholar
• Lewis G, Wessely S. Comparison of the General Health Questionnaire and the Hospital Anxiety and Depression Scale. Br J Psychiat 1990;157:860–4.
   PubMed Web of Science ®Google Scholar
• Razavi D, Delvaux N, Farvacques C, Robaye E. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiat 1990;156:79–83.
   PubMed Web of Science ®Google Scholar
• Moorey S, Greer S, Watson M, Gorman C, Rowden L, Turmore R, Robertson B, Bliss J. The factor structure and factor stability of the Hospital Anxiety and Depression Scale in patients with cancer. Br J Psychiat 1991;158:255–9.
   PubMed Web of Science ®Google Scholar
• Hopwood P, Howell A, Maguire P. Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires. Br J Cancer 1991;64:349–52.
   Google Scholar
• Aaronson NK, Beckmann J, editors. The Quality of Life of Cancer Patients. New York: Raven Press, 1987.
   Google Scholar
• Katz S, editor. The Portugal Conference: Measuring quality of life and functional status in clinical and epidemiological research. J Chron Dis 1987;40:459–650.
   PubMedGoogle Scholar
• Feeny D, Guyatt G, Patrick D, editors. Proceedings of the International Conference on the Measurement of Quality of Life as an Outcome in Clinical Trials. Controlled Clin Trials 1991;12:795–2805.
   Google Scholar
• Shumaker SA, Ganz PA, Moinpour CM, Liang MH, Aaronson NK, Kane RL. Design and implementation issues. I: Health-related quality of life assessment in clinical research. In: National Institutes of Health. Quality of Life Assessment: Practice, Problems, and Promise. Proceedings of a workshop — October 15–17, 1990. U.S. Dept. of Health and Human Services, 1993. NIH Pub. No. 93–3503.
   Google Scholar
• Moinpour CM, Feigl P, Metch B, Hayden ICA, Meyskens FL, Crowley J. Do we need a new end point in clinical trials today? (letter) J Natl Cancer Inst 1989;81:1106.
   Google Scholar
• Calman KC. Definitions and dimensions of quality of life. In: Aaronson NK, Beckmann J, editors. The Quality of Life of Cancer Patients. New York: Raven Press, 1987:1–9.
   Google Scholar